Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Affinity Equity Partners Acquires Australian Diagnostic Imaging Provider for $658 Million
Hong Kong-based Affinity Equity Partners announced that it is acquiring radiology services provider Lumus Imaging from St Leonards, Australia-based healthcare company Healius Limited for A$965 million (approximately $658 million USD). Lumus Imaging is a Sydney, Australia-based diagnostic imaging company. It is made up of a team of radiographers, sonographers, nuclear medicine technologists and nurses. It has more than 2,000 diagnostic imaging experts and support staff across 135 sites across Australia. Affinity Equity Partners is one of the largest Asian private equity firms in the world, with more than $14 billion in assets under management. It was founded in 1998. Healius expects to net... Read More »
Ballad Health Sells Laboratory Assets to Labcorp
Ballad Health announced that it is selling select operating assets of its outreach laboratory services to Labcorp. Ballad Health is a chain of hospitals headquartered in Johnson City, Tennessee. It was founded in 2018. LabCorp, an S&P 500 company, is a global life sciences company that is integrated with guiding patient care, providing clinical laboratory and end-to-end drug development services. The company provides information to help doctors, hospitals, pharmaceutical companies, researchers and patients make decisions. LabCorp has more than 80,000 employees across more than 100 countries and had reported annual revenue of $12.16 billion in 2023, according to the company’s 2023... Read More »
VION Biosciences Acquires Second Company in August 2024
VION Biosciences announced on August 29 its second transaction of the month with the acquisition of Texas-based Ansh Labs. Earlier in the month, VION acquired Echelon Biosciences, a Salt Lake City-based company that specializes in producing high-quality reagents and assays for the life sciences research community. The Ansh acquisition alongside the Echelon Biosciences acquisition, as well as the August 2023 acquisition of Aldon Corporation brings VION’s employee roster to nearly 100 employees. Ansh Labs is a Texas-based company that focuses on the development, production and distribution of high-quality immunoassay kits and reagents for research and clinical diagnostics. The... Read More »
Baxter Sells Kidney Care Segment to Carlyle for $3.5 Billion in Cash
Baxter International Inc. and funds managed by global investment firm The Carlyle Group announced on August 13 that they have signed a definitive agreement under which Carlyle will acquire the kidney-care unit of Baxter International. The unit will be named Vantive. The deal establishes Vantive as a leading standalone kidney care business backed by Carlyle’s global investment team and resources. Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. The company’s products, digital... Read More »
OhioHealth Sells Outreach Laboratory Services Business to Quest Diagnostics
OhioHealth, based in Columbus, Ohio, announced on July 10 that it had signed an agreement to sell certain assets of its outreach laboratory services business to Quest Diagnostics. OhioHealth is a family of not-for-profit hospitals and healthcare facilities serving central Ohio since 1891. Quest Diagnostics provides diagnostic testing information services in the United States and internationally. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States with approximately 50,000 employees. According to its most recent annual report, Quest Diagnostics generated $9.25 billion in annual revenues during FY 2023, and annual EBITDA of $1.7... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
